Dry age-related macular degeneration2020-01-24T14:42:04+01:00

STUDY AREAS/SCIENTIFIC RESEARCH – Dry age-related macular degeneration


MACULAR DEGENERATION refers to a retinal disorder which causes an alteration, reducing the functionality of the central area of the retina (the macula) leading to loss of central vision. It is most commonly associated with ageing of the eye: the macula, containing numerous light receptors, changes until it loses its characteristics. The incidence of AMD is rare before aged 55 years, but increases, especially after 75 years. The more severe form of the disease, known as “wet”, is less frequent and develops faster but is currently the only one considered treatable.

Initial symptoms are distorted images in the central area of the visual field, difficulty reading and carrying out close-up activities, which require looking at small details, loss of colour brilliance.

There are two forms of age-related macular degeneration, both are associated with alterations of the capillary microcirculation, which is typical of advanced age: the dry (or atrophic) form and the wet (or exudative) form. These should be considered as two separate disorders, as their prognosis and potential therapies are entirely different.

The dry, or atrophic form (85-90% of cases) is characterised by a progressive thinning of the central retina, through being poorly nourished by the capillaries, which consequently atrophies.


  • not to smoke;
  • doing moderate physical exercise;
  • protecting from ultraviolet rays which can damage the macula;
  • a correct diet with an intake of natural antioxidant and anti-inflammatory substances




Le informazioni, immagini, descrizioni e quanto altro riportato nel sito relativi a dispositivi medici non sono di natura pubblicitaria ma materiale informativo rivolto esclusivamente a Professionisti dell’area sanitaria. Pertanto proseguendo nella navigazione l’utente dichiara di essere un Professionista dell’area sanitaria. Riferimento:Ministero della Salute – “Nuove linee guida della pubblicità sanitaria concernente i dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici” del 28 Marzo 2013; Aggiornamento delle “Linee guida in merito all’utilizzo di nuovi mezzi di diffusione della pubblicità sanitaria” del 17 Febbraio 2010 - These statements have not been evaluated by the Food & Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Please contact your healthcare professional immediately if you experience any unwanted side effects. The information contained herein is for informational purposes only and does not establish a doctor-patient relationship. Please be sure to consult your physician before taking this or any other product. Statements regarding dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease or health condition.
Go to Top